Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Turing

- PMLiVE

FDA clears generic of Daraprim, the ‘poster drug’ for price-gouging

Drug hit headlines after price jumped from $13.50 to $750 overnight

- PMLiVE

France’s Innate Pharma eyes $100m Nasdaq IPO

Would help fund development of antibody-based immunotherapies

- PMLiVE

‘Missing protein’ biotech Stoke raises $142m in IPO

Continues pioneering research

‘Missing protein’ biotech Stoke raises $142m in IPO

Continues pioneering research

- PMLiVE

Theranos and its CEO settle ‘massive fraud’ charges

SEC says case is a lesson in truth-telling for those seeking to disrupt an industry

- PMLiVE

Post-Shkreli KaloBios pledges transparent pricing

Will seek input from “key stakeholders” and share reasoning behind pricing of drugs

- PMLiVE

KaloBios files for bankruptcy protection

San Francisco biopharma's shares imploded in the wake of Martin Shkreli's arrest

- PMLiVE

Shkreli fallout claims Turing jobs and KaloBios’ listing

Both firms continue to suffer with job cuts and de-listing from the Nasdaq

- PMLiVE

Update: Shkreli resigns as Turing CEO, ousted from KaloBios

Shares in KaloBios had been hit hard when news of his arrest broke

- PMLiVE

Turing CEO Shkreli arrested by FBI in securities fraud probe

Accused of illegally using stock from biopharma firm Retrophin to pay off debts

- PMLiVE

Express Scripts to offer alternative to Turing’s Daraprim

Andpromises to share compounded formulation with other healthcare payers

- PMLiVE

Bio investors react as Clinton tweet pledges pricing crackdown

Pharma companies come under scrutiny for pricing policies

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links